申请人:KING FAISAL UNIVERSITY
公开号:US11891390B1
公开(公告)日:2024-02-06
Pyrrolo[2,3-c][2,7]naphthyridine-2-carboxylic acid compounds are provided. The pyrrolo[2,3-c][2,7]naphthyridine-2-carboxylic acid compounds have the general formula:
where R
1
is H, C
1
-C
6
alkyl, or C
3
-C
6
cycloalkyl, and R
2
is C
1
-C
6
alkyl, C
1
-C
6
haloalkyl, C
1
-C
6
cyanoalkyl, (CH
2
)
2-3
NR
3
R
4
, (CH
2
)
1-2
aryl, (CH
2
)
1-2
heteroaryl, C(O)—(CH
2
)
2-3
NR
3
R
4
, C(O)aryl, C(O)heteroaryl, S(O)
2
—(CH
2
)
2-3
NR
3
R
4
, S(O)
2
aryl, S(O)
2
heteroaryl, C
3
-C
6
cycloalkyl, C
3
-C
6
halocycloalkyl, C
3
-C
6
cyanocycloalkyl, aryl, or 5- or 6-membered heteroaryl. The pyrrolo[2,3-c[2,7]naphthyridine-2-carboxylic acid compounds inhibit protein kinase CK2 activity and may be used as anticancer agents, as well as agents for treating inflammation, pain, immunological disorders, diabetes, viral infections, and neurodegenerative diseases.